Beyond Survival: Economic Analyses of Chemotherapy in Advanced, Inoperable NSCLC
February 1st 1998Research shows that chemotherapy for inoperable non-small-cell lung cancer (NSCLC) improves survival. The economic implications of this treatment choice may be substantial. This paper reviews studies examining the cost-